Can Melanotan II cause skin cancer?

There is genuine concern. Case reports document new and changing moles and at least one melanoma arising after use. It stimulates melanocytes, which could accompany or mask malignant change, so it is not a safe way to tan.

What are the most common side effects?

Reported effects include nausea and vomiting, facial flushing, yawning/stretching, appetite loss, darkening or eruption of moles, and, notably in men, spontaneous, sometimes prolonged and painful erections (priapism).

Is priapism from Melanotan II serious?

Yes. Case reports describe priapism, including low-flow priapism that required emergency treatment (cavernosal aspiration and phenylephrine). Untreated priapism can cause permanent damage and is a medical emergency.

Why do regulators warn against it?

Because it is unlicensed, often injected from unregulated online sources with no purity or dose control, and is associated with documented harms ranging from priapism to melanocytic changes and a reported melanoma.

Research chemical — not approvedaka MT-II, MT2

Melanotan II — Complete Research Guide (2026)

Last updated 2026-06-25

TL;DR

A synthetic melanocortin agonist studied for skin pigmentation and sexual function. Sold illegally in many regions; associated with notable safety concerns including melanoma risk discussion.

What is Melanotan II?

Melanotan II is a synthetic cyclic melanocortin-receptor agonist marketed illicitly as an injectable tanning peptide. It is NOT approved or licensed as a medicine anywhere; regulators including the EMA and national agencies (e.g. UK MHRA, Australia's TGA, and EU/Dutch authorities) have warned that it is unlicensed, sold illegally, and linked to serious harms.

The human evidence base is dominated by case reports and pharmacovigilance rather than controlled trials, and documented adverse effects are substantial.

How does Melanotan II work?

Melanotan II non-selectively activates melanocortin receptors, notably MC1R on melanocytes, driving eumelanin production and skin darkening, and central MC3/MC4 receptors, which underlies effects such as spontaneous erections, nausea, and appetite suppression. [INFOGRAPHIC: Melanotan II melanocortin receptor activation]

What does the research say about Melanotan II?

Melanotan II does darken skin by activating MC1R to increase eumelanin, but this is not a safe cosmetic shortcut: the same melanogenic and melanocyte-stimulating activity has been tied in case reports to eruptive and changing moles. ^[1]
It is an unlicensed, unregulated product of public-health concern to dermatologists, sold online outside any medicines framework, so even its intended tanning effect comes with no quality control over dose, sterility, or purity. ^[6]
Any perceived benefit must be weighed against documented harm: a melanoma arising in a pre-existing mole after Melanotan use has been reported, raising concern that melanocyte stimulation may accompany or obscure malignant change. ^[2]

Clinical research & studies

The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.

[1] Eruptive melanocytic naevi following melanotan injection — Cousen P et al., Br J Dermatol 2009. (case report)
[2] Melanotan-associated melanoma — Paurobally D et al., Br J Dermatol 2011. (case report)
[3] Changes of melanocytic lesions induced by Melanotan injections and sun bed use in a teenage patient with FAMMM syndrome — Sivyer GW, Dermatol Pract Concept 2012. (case report)
[4] Melanotan II overdose associated with priapism — Devlin J et al., Clin Toxicol (Phila) 2013. (case report)
[5] Melanotan-induced priapism: a hard-earned tan — Dreyer BA et al., BMJ Case Rep 2019. (case report)
[6] The unregulated use of melanotan-II is of public health interest to Australian dermatologists — Adler NR et al., Australas J Dermatol 2017. (commentary / public-health article)

Dosing context

This is not medical advice or a usage recommendation. Dosing figures are reported research context only, cited from the published literature.

For context only: illicit products are injected subcutaneously with loading and maintenance regimens promoted on unregulated forums, but no legitimate dosing exists because Melanotan II is not an approved medicine and doses/products are unstandardized.

No dosing guidance is provided here; the documented harms and lack of regulation mean any use is discouraged.

Side effects & safety profile

Documented adverse effects of Melanotan II include nausea and vomiting, facial flushing, spontaneous yawning/stretching, appetite loss, and darkening of existing moles as well as new and atypical melanocytic naevi; a reported melanoma following use is especially concerning.

Case reports also describe priapism (prolonged, painful erection, including low-flow priapism requiring emergency cavernosal aspiration and phenylephrine), and the broader literature links melanocortin misuse to events such as rhabdomyolysis.

Because it is unlicensed and injected, users also risk contamination and dosing errors, and regulators (EMA and national agencies) explicitly warn against its use; it should be regarded as unsafe and not for human use.

Stacking & combinations

Melanotan II is sometimes combined with UV exposure or other agents, which only compounds the melanoma and adverse-event concerns rather than mitigating them.

Finding Melanotan II vendors

This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.

Choose your country

We never list placeholder vendors. Pick your country to see neutral regulatory context.

Browse the directory

User reviews

No reviews yet

Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.

Frequently asked questions

No. It is unlicensed and not approved anywhere. Regulators including the EMA and national agencies have warned it is sold illegally and is linked to serious side effects.

References

[1] Eruptive melanocytic naevi following melanotan injection — Cousen P et al., Br J Dermatol 2009. PMID: 19575725. View sourceStudy: case reportMultiple new melanocytic naevi erupted following melanotan injection.
[2] Melanotan-associated melanoma — Paurobally D et al., Br J Dermatol 2011. PMID: 21564053. View sourceStudy: case reportReports a melanoma developing in a pre-existing naevus after Melanotan injections.
[3] Changes of melanocytic lesions induced by Melanotan injections and sun bed use in a teenage patient with FAMMM syndrome — Sivyer GW, Dermatol Pract Concept 2012. PMID: 23785612. View sourceStudy: case reportDocuments pigmentary/melanocytic-lesion changes after Melanotan use in a high-risk (FAMMM) teenager.
[4] Melanotan II overdose associated with priapism — Devlin J et al., Clin Toxicol (Phila) 2013. PMID: 23537392. View sourceStudy: case reportMelanotan II overdose was associated with priapism, illustrating its central melanocortin effects.
[5] Melanotan-induced priapism: a hard-earned tan — Dreyer BA et al., BMJ Case Rep 2019. PMID: 30796078. View sourceStudy: case reportDescribes priapism requiring intervention after melanotan use.
[6] The unregulated use of melanotan-II is of public health interest to Australian dermatologists — Adler NR et al., Australas J Dermatol 2017. PMID: 28905366. View sourceStudy: commentary / public-health articleFrames unregulated Melanotan II use as a public-health concern given documented harms and lack of oversight.

Related peptides

PT-141Sexual Health Kisspeptin-10Sexual Health

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.